Dec 1, 2021, 14:57 by Bob Davis

OHSAM sent a letter to members of the Senate Committee on Small Business and Economic Opportunity opposing SB 261. SB 261 would update the regulatory framework governing the state’s medical cannabis program.

Nov 19, 2021, 02:00 by Bob Davis

Nation’s leading association of addiction medicine physicians and other clinicians commend inclusion of provisions that would improve equitable coverage and access to comprehensive addiction care, and reduce the shortages of, and strengthen, the addiction treatment workforce

Nov 17, 2021, 14:50 by Jaida Montenegro

Conversation on the Future of Science Research of Addiction Medicine with Nora Volkow, MD, Director of the National Institute on Drug Abuse (NIDA) at the National Institutes of Health (NIH), and Maureen Boyle, PhD, Chief Quality and Science Officer at ASAM.

Nov 9, 2021, 02:00 by Bob Davis

The new toolkit, authored by Manatt Health Strategies in collaboration with the American Society of Addiction Medicine and Well Being Trust, provides ways for ensuring consistent use of patient-centered addiction care across providers, payers, and patients

Nov 5, 2021, 02:00 by Jaida Montenegro

On November 5th, ASAM sent a letter to Senators Chris Murphy and Bill Cassidy in response to their request for input on policies to improve mental health and substance use disorder care.

Nov 1, 2021, 02:00 by Bob Davis

On July 1, 2020, Louis Baxter, Sr., MD, DABAM, DFASAM, watched with gratitude as a vision he helped cast became a reality. That day marked the inaugural graduation of fellows from Howard University Medical School’s new Addiction Medicine Fellowship Program. Dr. Baxter, the program’s co-founder and director, helped establish the program with the goal of providing addiction medicine services to underprivileged patients in the DC metropolitan area.

Nov 1, 2021, 02:00 by Jaida Montenegro

On November 1st, the Michigan Society of Addiction Medicine (MISAM) sent a letter to the membership of the House Committee on Health Policy in support of SB 412. If enacted, SB 412 would remove prior authorization requirements on FDA-approved medications for opioid use disorder within the state’s Medicaid program.

Oct 28, 2021, 02:00 by Jaida Montenegro

This statement highlights specific policy recommendations to improve both access to, and the quality of, methadone treatment for OUD by making it more patient-centered and integrated with other medical care.

Oct 15, 2021, 02:00 by Jaida Montenegro

On October 13th, ASAM, along with members of the Coalition to Stop Opioid Overdose (CSOO) and members of the Mental Health Liaison Group (MHLG), sent a letter to Chairman Ron Wyden and Ranking Member Mike Crapo of the Senate Committee on Finance, encouraging full extension of federal mental health and substance use disorder parity protections to Medicare, all of Medicaid, and TRICARE.

Oct 4, 2021, 02:00 by Jaida Montenegro

On October 4th, the Ohio Society of Addiction Medicine (OHSAM) sent a letter to Senator Terry Johnson of the Ohio General Assembly highlighting concerns with his recently introduced bill SB 216 or “Dylan’s Law.”

Sep 29, 2021, 02:00 by Jaida Montenegro

The American Society of Addiction Medicine and the American Medical Association today released new recommendations as part of the AMA Substance Use and Pain Care Task Force to help end the nation’s drug-related overdose and death epidemic.

Sep 17, 2021, 02:00 by Jaida Montenegro

On September 17th, the Northern New England Society of Addiction Medicine (NNESAM) sent a letter to Governor Janet Mills urging her to reinstate Executive Order 27, which expanded syringe services programs (SSPs) in Maine.

Sep 16, 2021, 02:00 by Jaida Montenegro

On September 10th, the American Society of Addiction Medicine (ASAM) submitted a comment letter to the Centers for Medicare & Medicaid Services (CMS) outlining suggested improvements to the proposed Physician Payment Schedule for calendar year (CY) 2022.

Sep 13, 2021, 01:00 by Jaida Montenegro

On September 10th, the American Society of Addiction Medicine (ASAM), along with dozens of partner organizations, sent a letter to Chair Patty Murray of the Senate Committee on Health, Education, Labor, and Pensions (HELP) urging for the inclusion of enhanced mental health and substance use disorder (SUD) parity enforcement within the Senate’s version of the budget reconciliation proposal.

Sep 13, 2021, 01:00 by Jaida Montenegro

On September 9th, the Michigan Society of Addiction Medicine (MISAM) submitted a comment letter to the Michigan Bureau of Professional Licensing in support of proposed changes to the pharmacy controlled substances rules of the Drug Treatment Prescriber Program. These revisions would eliminate burdensome requirements on the licensing of controlled substances and bring the state rules into closer alignment with federal standards.

Sep 2, 2021, 01:00 by Jaida Montenegro

On September 1st, the Michigan Society of Addiction Medicine (MISAM) sent a letter to Director Hawks of the Michigan Department of Licensing and Regulatory Affairs (LARA) to highlight concerns about the department’s regulation of medication for addiction treatment (MAT).

Aug 31, 2021, 01:00 by Jaida Montenegro

On August 23rd, ASAM joined with a coalition of 45 partner organizations to send a letter to the leadership of the House Energy and Commerce Committee in support of the Moms Matter Act (H.R. 909).

Aug 24, 2021, 01:00 by Jaida Montenegro

On August 24th, ASAM sent a letter to Representative Cohen affirming its strong support for the Making Essentials Affordable and Lawful (MEAL) Act of 2021 (H.R. 2837). This proposed legislation would remove the federal ban prohibiting individuals with felony drug convictions from receiving Supplemental Nutrition Assistance Program (SNAP) and Temporary Assistance for Needy Families (TANF) benefits.

Aug 18, 2021, 16:20 by admin admin

Aug 18, 2021, 16:19 by admin admin